By Nev Zuberick DO, Chief Medical Officer.
Electrome is advancing bioelectric medicine to treat pain and inflammation by restoring the body’s electrical balance, offering personalized, non-drug therapies that reduce reliance on opioids and improve patient outcomes.
Introduction
Pain and inflammation remain two of medicine’s most persistent and costly challenges, driving disability and diminished quality of life for hundreds of millions worldwide. Conventional drug therapies often provide incomplete relief and carry risks of side effects, dependency, or long-term toxicity.
Bioelectric medicine offers a fundamentally new approach. By using targeted electrical signals to reset the circuits underlying pain transmission and immune activation, clinicians can modulate biological processes at their source. Electrome is helping to drive this transformation, combining clinical insight, engineering, and AI-driven discovery to expand what’s possible in pain and inflammation management.
Beyond the Pill: Understanding the Electrical Roots of Pain
Pain is, at its essence, an electrical event. Nerve injury or chronic irritation alters membrane potentials, disrupts ion channel dynamics, and establishes maladaptive pain loops that drugs alone cannot resolve. Imaging studies reveal persistent “electrical echo chambers” within spinal and brain circuits that perpetuate pain long after tissues heal.
“Pain becomes less about the original injury and more about the circuits that refuse to turn off,” explains Dr. Zubcevik. “That’s why bioelectric reset is so powerful.”
How Bioelectric Modulation Changes the Story
Bioelectric therapies deliver carefully measured pulses to interfere with pain signaling and inflammation at multiple levels. They can block nociceptive transmission, regulate voltage-gated ion channels, stimulate endogenous opioid release, and promote neuroplastic resetting of maladaptive circuits.
Unlike pharmaceuticals, which broadly alter chemistry, bioelectric devices can be tuned to the patient’s own physiology. With closed-loop feedback, therapies adapt dynamically to real-time nerve and immune responses.
Bringing Bioelectric Relief to Patients
Bioelectric devices are increasingly adopted for conditions such as back pain, arthritis, migraines, sciatica, neuropathies, and fibromyalgia. Wearable and wireless devices now enable patients to self-manage care at home, reducing reliance on long-term medications and frequent hospital visits.
“This is a patient-driven model,” says Dr. Wanni Davis, COO. “Smart devices learn from biosensor input and personalize therapy over time.”
Inflammation: Reprogramming the Immune Response
Inflammation is also fundamentally electrical. Cytokine release, vagus nerve signaling, and lymphoid activation are all shaped by electrical cues. Bioelectric therapies such as vagus nerve stimulation have been shown to reduce cytokine storms in conditions ranging from rheumatoid arthritis to Crohn’s disease and even COVID-19 (1–3).
By engaging endogenous anti-inflammatory pathways, bioelectric devices provide precision immune modulation without the broad immunosuppression of many drugs.
Clinical Validation and Adoption
Dozens of device classes have now been reviewed and cleared by the FDA and international agencies. Clinical trials consistently demonstrate reduced opioid use, faster recovery, fewer hospitalizations, and improved quality of life in patients using bioelectric therapies for pain and inflammatory disorders (1–3).
“As we advance bioelectric medicine, we must consider the system-wide benefits,” notes Ken Mayer, CEO of Electrome. “The opportunity is not only clinical, it is economic.”
Economic and Societal Outlook
Bioelectric pain and inflammation therapies address not only rising care costs but also the opioid crisis and disparities in rural-urban access. Cloud-connected platforms and modular designs enable scalable adoption across hospitals, clinics, and home care.
As real-world evidence accumulates, ongoing device upgrades can be rapidly deployed, amplifying both patient and system-level benefits.
Conclusion
Bioelectric medicine is redefining how we approach pain and inflammation. By targeting the electrical circuits that underlie these conditions, Electrome’s adaptive platforms promise safer, personalized, and more effective solutions. As adoption grows, pain and inflammation management is poised to enter an era of individualized, data-driven, and system-sustaining care.
References
- Eberhardson M, Tarnawski L, Centa M, Olofsson PS. Neural Control of Inflammation: Bioelectronic Medicine in Treatment of Chronic Inflammatory Disease. Cold Spring Harb Perspect Med. 2020 Mar 2;10(3):a034181. doi: 10.1101/cshperspect.a034181. PMID: 31358521; PMCID: PMC7050580.
- Boland JL, Tütüncüoglu G, Gong JQ, Conesa-Boj S, Davies CL, Herz LM, Fontcuberta I Morral A, Johnston MB. Towards higher electron mobility in modulation doped GaAs/AlGaAs core shell nanowires. Nanoscale. 2017 Jun 14;9(23):7839-7846. doi: 10.1039/c7nr00680b. PMID: 28555685.
- Levin M. The rise of bioelectric medicine sparks interest among researchers. Proc Natl Acad Sci U S A. 2019;116(49):24379–24381. doi:10.1073/pnas.1919040116. PNAS
- WebMD. Pain Management and Bioelectric Therapy. 2024. Link
- Allied Market Research. Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion Globally by 2032. PRNewswire. 2024. Link
- Electrome | Precision Bioelectric Therapeutics. https://electrome.io
SetPoint Medical. Activating the body’s natural healing response. https://setpointmedical.com